CFGS
LKFT

Concourse Financial Group Securities’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Concourse Financial Group Securities’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-686
Closed -$40.7K – 2432
2021
Q2 		$47K Sell
686
-127
-16% -$9.69K ﹤0.01% 1337
2021
Q1 		$63K Buy
813
+154
+23% +$14.2K ﹤0.01% 1126
2020
Q4 		$65K Buy
659
+314
+91% +$38.4K ﹤0.01% 1068
2020
Q3 		$49K Buy
345
+67
+24% +$11.2K ﹤0.01% 1075
2020
Q2 		$55K Buy
278
+21
+8% +$4.35K 0.01% 952
2020
Q1 		$50K Buy
257
+8
+3% +$1.72K 0.01% 908
2019
Q4 		$52K Buy
249
+60
+32% +$11.1K 0.01% 934
2019
Q3 		$29K Buy
189
+68
+56% +$11.1K 0.01% 816
2019
Q2 		$16K Buy
121
+94
+348% +$11.2K ﹤0.01% 1328
2019
Q1 		$3K Buy
+27
New +$2.72K ﹤0.01% 1921

Other funds holding LKFT

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Concourse Financial Group Securities's LKFT Position: Q3 2021 in Review

Concourse Financial Group Securities sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q3 2021, closing a stake of 686 shares — an estimated $40.7K sold.

Concourse Financial Group Securities first reported a position in LKFT in Q1 2019 and held it in 10 quarters. The position peaked at $65K in Q4 2020. 81 funds tracked by Wall St. Rank hold LKFT as of Q3 2021.

  • Concourse Financial Group Securities reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q3 2021 after selling out during the quarter.
  • Concourse Financial Group Securities sold 686 Lakefront Biotherapeutics American Depositary Shares shares in Q3 2021, an estimated $40.7K.
  • Concourse Financial Group Securities first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2019 and held it in 10 quarters.
  • Concourse Financial Group Securities's Lakefront Biotherapeutics American Depositary Shares position peaked at $65K in Q4 2020.
  • 81 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2021.

Based on Concourse Financial Group Securities's 13F filing for Q3 2021, filed 9 Nov 2021.